Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6735587 | 1.00 | PPARA (0.48) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL2981518 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL11503930 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL5604764 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL3308963 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL10962186 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL11504441 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL11505423 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL11505457 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN | |
| SCHEMBL4890657 | 0.98 | PPARA (0.52) | PPARAFAAHTRPV1EPHX2GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115073627-B | Porous organic polymer carrier metallocene catalyst system and preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-115073627-A | Porous organic polymer carrier type metallocene catalyst system and preparation method and application thereof | 中国石油天然气股份有限公司 | 2022-09-20 | — | — | CN | claimed |
| US-20150132797-A1 | COMPOSITION, METHOD AND KIT FOR REDUCING BACKGROUND STAINING | LIFE TECHNOLOGIES CORP (US) | 2015-05-14 | — | — | US | claimed |
| US-20100285601-A1 | METHOD OF ELECTRICALLY DETECTING A NUCLEIC ACID MOLECULE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-11-11 | — | — | US | claimed |
| WO-2009041917-A1 | METHOD OF ELECTRICALLY DETECTING A NUCLEIC ACID MOLECULE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-04-02 | — | — | WO | claimed |
| US-20080038772-A1 | COMPOSITION, METHOD AND KIT FOR REDUCING BACKGROUND STAINING | INVITROGEN CORPORATION (US) | 2008-02-14 | — | — | US | claimed |
| US-20080038773-A1 | COMPOSITION, METHOD AND KIT FOR REDUCING BACKGROUND STAINING | INVITROGEN CORPORATION (US) | 2008-02-14 | — | — | US | claimed |
| CN-1089614-A | Alpha-phosphonosulfonate squalene synthetase inhibitors and method | SQUIBB & SONS INC (US) | 1994-07-20 | — | — | CN | claimed |
| EP-4713509-A1 | PROTON EXCHANGE MEMBRANE AND CATALYST-COATED PROTON EXCHANGE MEMBRANE | UOP LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024263501-A1 | PROTON EXCHANGE MEMBRANE AND CATALYST-COATED PROTON EXCHANGE MEMBRANE | UOP LLC (US) | 2024-12-26 | — | — | WO | disclosed |
| EP-3073499-B1 | NON-AQUEOUS LITHIUM-TYPE POWER STORAGE ELEMENT | ASAHI CHEMICAL IND (JP) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023204215-A1 | ELECTRODE COMPOSITION FOR LITHIUM ION BATTERIES, COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, AND LITHIUM ION BATTERY | ＡＰＢ株式会社 | 2023-10-26 | — | — | WO | disclosed |
| US-20230327119-A1 | COATED POSITIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERY | APB CORPORATION (JP) | 2023-10-12 | — | — | US | disclosed |
| CN-116410371-A | Z-N type catalyst system for ethylene polymerization and preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | disclosed |
| US-20030138397-A1 | Anionic polymers as toxin binders and antibacterial agents | GELTEX PHARMACEUTICALS, INC. | 2003-07-24 | — | — | US | disclosed |
| US-6517827-B1 | Polystyrene sulfonate polymer; Clostridium difficile | GELTEX PHARMACEUTICALS, INC. | 2003-02-11 | — | — | US | disclosed |
| US-6517826-B1 | Polystyrene sulfonate polymer; Clostridium difficile | GELTEX PHARMACEUTICALS, INC. | 2003-02-11 | — | — | US | disclosed |
| EP-1189622-A2 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | Geltex Pharmaceuticals, Inc. (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6290946-B1 | ADMINISTERING TO THE ANIMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF A POLYMER HAVING A PLURALITY OF PENDANT ACID FUNCTIONAL GROUPS WHICH ARE DIRECTLY ATTACHED TO THE POLYMER BACKBONE OR ATTACHED TO THE POLYMER BACKBONE BY A SPACER GROUP. | GELTEX PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | disclosed |
| WO-2000069428-A2 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 2000-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138397-A1 | Anionic polymers as toxin binders and antibacterial agents | MSN, ANTXR2, PNKP | PPARA 3390/4885FAAH 2469/4885TRPV1 2841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.